Methyl 4,4-Difluorocyclohexanecarboxylate, 97.0%, 10g

2-(2-Chloroethoxy)benzenesulfonamide, 95.0%, 100g

2-((Pyridin-4-ylmethyl)amino)nicotinic acid, 95+%, 1g

(5AR,10bS)-2-(4-methoxyphenyl)-5a,10b-dihydro-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 97.0%, 100mg

tert-butyl 5-oxo-1,4,9-triazaspiro[5.5]undecane-9-carboxylate, 95.0%, 10g

4,6-Diaminopyrimidine, 98.0%, 5g

(R)-4-Amino-2-ethylisoxazolidin-3-one hydrochloride, 97%, 250mg

Chitosan (20-100mPa.s, 0.5% in 0.5% Acetic Acid at 20deg C)100g

3-(1H-Indol-3-yl)propanamide, 95.0%, 5g

2-(Chloromethyl)-6-methoxy-3-(trifluoromethyl)pyridine, 97.0%, 100mg

Sodium deuterium oxide, 30% solution in D2O, 99.5 at%D, 10 ml, glass packaging

5-(TRIFLUOROMETHYL)-1,3,4-THIADIAZOL-2(3H)-ONE, 95.0%, 100mg

4-Hydroxy-5-methylfuran-3(2H)-one, 95.0%, 100g